Showing results (161-170 of 245) with videos related to
Sort By:
Pageof 25
The Journal of Infectious Diseases|September 19, 2021
Effectiveness of Pneumococcal Vaccination Against Pneumococcal Pneumonia Hospitalization in Older Adults: A Prospective, Test-Negative StudyJung Yeon Heo, Yu Bin Seo, Won Suk Choi, et al.Human Vaccines & Immunotherapeutics|November 6, 2019
Age-stratified analysis of serotype-specific baseline immunity against group B streptococcusMin Joo Choi, Ji Yun Noh, A-Yeung Jang, et al.Journal of Korean Medical Science|February 6, 2024
Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in KoreaEliel Nham, Jin Gu Yoon, Min Joo Choi, et al.Infection & Chemotherapy|January 21, 2016
Viral Shedding and Environmental Cleaning in Middle East Respiratory Syndrome Coronavirus InfectionJoon Young Song, Hee Jin Cheong, Min Joo Choi, et al.Journal of Korean Medical Science|November 10, 2010
Liver abscess and empyema due to Lactococcus lactis cremorisHye Sook Kim, Dae Won Park, Young Kyoung Youn, et al.Frontiers in Immunology|April 13, 2023
Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosisHye Seong, Jun Hyoung Kim, Young-Hee Han, et al.Journal of Clinical Medicine|December 9, 2023
Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-AnalysisYu Jung Choi, Yu Bin Seo, Jun-Won Seo, et al.Vaccine|August 29, 2015
Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trialJoon Young Song, Hee Jin Cheong, Jacob Lee, et al.Vaccines|March 26, 2022
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50-64 Years, and At-Risk Adults Aged 19-64 YearsMin Joo Choi, Gyeongseon Shin, Daewon Kang, et al.Frontiers in Immunology|May 17, 2024
Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccinationHakjun Hyun, Eliel Nham, Hye Seong, et al.Pageof 25